Based in Hyderabad, India, Bharat Biotech is expanding its vaccine portfolio with a focus on antimicrobial resistance (AMR), a growing global health challenge. The company, known internationally for developing Covaxin during the Covid-19 pandemic, is now working on vaccines designed to prevent hospital-acquired infections, particularly in patients undergoing surgeries. According...
Aurigene Pharmaceutical to Invest in India’s Genome Valley
Aurigene Discovery Technologies Limited, a research, development, and manufacturing services organization and subsidiary of Dr. Reddy's Laboratories, announced plans to construct a development and manufacturing facility for therapeutic proteins, antibodies, and viral vectors in Genome Valley at Hyderabad, India. As the first phase of investment, Aurigene will invest $40 million...